Partnership Forums
AMCP Partnership Forums bring together key decision-makers in various managed care industries to discuss and collaborate on strategies to drive efficiency and improve patient outcomes in an interactive environment. Designed to address current market challenges and opportunities, AMCP Partnership Forums also:
- Take a proactive, collaborative approach to solving critical issues and challenges.
- Gain consensus on removing barriers to improve patient care and optimize value for all stakeholders.
- Provide opportunities for payers, manufacturers, patients, and other stakeholders to collaborate on common goals and interests and create actionable results.
- Experience high visibility among industry stakeholders and policymakers.
Partnership Forums:
June 24-25, 2025
A Unified Approach: Advancing Precision Medicine in Oncology
Description
Despite its promise, significant gaps persist slowing the widespread adoption of precision medicine, particularly around clinical and payer decision-making related to biomarker testing and targeted therapies. Challenges such as misalignment between managed care policies and clinical guidelines, reimbursement barriers, and health equity concerns. Addressing these gaps is essential to ensure precision medicine can be effectively implemented to benefit diverse patient populations. AMCP's Partnership Forum will bring together key stakeholders to explore strategies for advancing precision medicine. Attendees will engage in discussions on best practices for integrating biomarker testing and targeted therapies into clinical and payer decision-making while identifying challenges and actionable solutions. The meeting is part of a broader precision medicine initiative AMCP is undertaking to shape policy, enhance collaboration, and improve healthcare outcomes.
Nov. 12-13, 2024
Closing the Gap in Real-World Evidence Use: A Collaborative Approach for Health Care Transformation
Program Guide
Description
Real-world evidence (RWE) is increasingly used to support epidemiologic studies, safety and effectiveness studies, and even contribute to clinical trials or as evidence included in regulatory submissions. However, RWE has a much less prominent role in payer decision-making, particularly due to challenges such as a lack of standards and guidelines for how to evaluate and use RWE, lack of experience in applying RWE to formulary decisions, and lack of understanding how RWE could be most impactful for payer decisions. AMCP is developing standards and resources to support RWE interpretation and application to formulary and medical policy decisions. These standards aim to align RWE definitions, improve the transparency in RWE generation, increase consistency in how sponsors develop and share RWE, and support the ongoing communication between payers and pharmaceutical manufacturers.
This Partnership Forum will convene multi-stakeholder experts to develop resources that will address barriers to RWE use in formulary decision-making through workshop and collaborative activities that will result in a set of RWE standards and tools to facilitate stakeholder communication and streamline the use of RWE.
Learn more about the AMCP Research Institute Real World Evidence (RWE) Initiative.
See proceedings and findings from this Partnership Forum.
